# US Hip Implants Market

> US Hip Implants Market Research Report By Product Type (Total Hip Replacement Implants, Fixed-Bearing Hip Implants, Mobile-Bearing Total Hip Implants, Partial Hip Replacement Implants, Hip Resurfacing Implants, Revision Hip Replacement Implants), By End User (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers) and By Material (Metal-on-Polyethylene, Ceramic-on-Metal, Metal-on-Metal, Ceramic-on-Polyethylene, Ceramic-on-Ceramic) - Growth & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 3.37%
- **2024:** $ 2,500 Million
- **2025:** $ 2,584.25 Million
- **2035:** $ 3,600 Million
- **Key Players:** Johnson & Johnson (US), Stryker Corporation (US), Zimmer Biomet (US), Smith & Nephew (GB), DePuy Synthes (US), Medtronic (US), B. Braun Melsungen AG (DE), Exactech (US)

**Report ID:** MRFR/MED/17841-HCR · **Pages:** 100 · **Author:** Nidhi Mandole & Rahul Gotadki · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/us-hip-implants-market-19388

---

## Market Summary

## **US Hip Implants Market Overview**

As per MRFR analysis, the US Hip Implants Market Size was estimated at 2.41 (USD Billion) in 2023. The US Hip Implants Market Industry is expected to grow from 2.85(USD Billion) in 2024 to 4.38 (USD Billion) by 2035. The US Hip Implants Market CAGR (growth rate) is expected to be around 4.001% during the forecast period (2025 - 2035).

### **Key US Hip Implants Market Trends Highlighted**

The US Hip Implants Market is currently experiencing several significant trends driven by various factors. One key market driver is the aging population in the United States, which is leading to an increased prevalence of hip-related conditions such as osteoarthritis and fractures. The demand for hip replacement surgeries is growing as more older adults seek to improve their quality of life and mobility. Moreover, advances in surgical techniques and implant technology are enhancing patient outcomes, which is encouraging more patients to opt for these procedures. 

There are also opportunities to be explored, particularly in the area of personalized medicine.Custom-made implants that are tailored to the physiological needs of individual patients are gaining traction. This personalized approach not only improves surgical success rates but also reduces recovery times. Additionally, as the healthcare system in the US shifts towards value-based care, there is a greater focus on cost-effective implant options that provide long-term benefits to patients and healthcare providers alike. 

Recent trends include the growing adoption of minimally invasive surgical techniques, which are associated with lower rates of complications and shorter hospital stays. The rise of outpatient hip replacement programs is also making the procedure more accessible, allowing patients to recover at home rather than in extended hospital stays.Furthermore, the expansion of telemedicine is being utilized for preoperative assessments and follow-ups, particularly useful in rural areas where access to healthcare is limited. These developments indicate that the US Hip Implants Market is evolving rapidly, reflecting broader trends in healthcare toward improved patient-centered care and technological integration.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **US Hip Implants Market Drivers**

### **Increasing Aging Population**

The demographic shift towards an aging population is a significant driver for the US Hip Implants Market Industry. According to the U.S. Census Bureau, the proportion of the population aged 65 years and older is projected to rise from 15 percent in 2016 to nearly 22 percent by 2040. This demographic change leads to a higher incidence of age-related musculoskeletal disorders, ultimately driving demand for hip implants.

Additionally, the American Academy of Orthopaedic Surgeons reports that by 2030, there will be an estimated 4 million total hip replacements performed annually in the United States.This surge in hip replacement procedures is directly correlated with the aging population, indicating a robust market for hip implants.

### **Technological Advancements in Implant Design**

The US Hip Implants Market Industry is significantly influenced by continuous technological innovations in implant design. With substantial investments in Research and Development (R&D), companies are developing advanced materials and smarter designs to enhance the longevity and performance of hip implants. The Food and Drug Administration (FDA) has reported an increase in the approval of innovative orthopedic devices, thus encouraging competition.For instance, new minimally invasive surgical techniques are reducing recovery time for patients, and implant durability has increased due to improved materials.

These advancements contribute to an expected rise in elective surgeries as patients are more likely to opt for procedures that promise lower risk and faster recovery.

### **Rising Prevalence of Obesity**

The increasing prevalence of obesity among the U.S. population is a notable driver for the US Hip Implants Market Industry. The Centers for Disease Control and Prevention (CDC) states that approximately 42.4 percent of adults in the United States were classified as obese in 2017-2018, a significant rise from previous years.

Obesity is a known risk factor for osteoarthritis and other joint disorders, leading to a higher demand for hip replacement surgeries.With the American Joint Replacement Registry noting that nearly 25 percent of patients undergoing hip replacement are overweight or obese, the demand for hip implants is anticipated to grow as obesity rates continue to rise.

### **Increased Awareness and Acceptance of Joint Replacement Surgeries**

There is a growing awareness and acceptance of hip joint replacement surgeries among the U.S. population, which is positively impacting the US Hip Implants Market Industry. Educational initiatives led by healthcare organizations, such as the American Academy of Orthopaedic Surgeons, are promoting the benefits of these procedures.

According to the National Institutes of Health, patient education about the effectiveness and safety of hip implants is increasing the willingness of patients to undergo surgery.As a result, projections indicate that the demand for hip replacements will increase, with an anticipated growth in the number of elective procedures performed in hospitals and outpatient settings.

## **US Hip Implants Market Segment Insights**

### **Hip Implants Market Product Type Insights**

The US Hip Implants Market is a critical and dynamic segment within the orthopedic industry, comprising various product types that cater to the diverse needs of patients suffering from hip-related ailments. Total Hip Replacement Implants, which are often the most commonly utilized in surgical procedures, have a significant role in restoring mobility and quality of life for patients. Their importance stems from the growing prevalence of degenerative diseases such as osteoarthritis, particularly among the aging population, which is a key demographic in the US.

Following closely, Fixed-Bearing Hip Implants remain popular due to their stability and lower wear rates, contributing to their demand in the market. Mobile-Bearing Total Hip Implants are recognized for offering increased range of motion and may appeal to younger and more active patients, leading to their significant presence in the market. 

Likewise, Partial Hip Replacement Implants present a viable alternative for patients who experience less severe joint degradation, providing targeted relief and facilitating quicker recovery times, thereby capturing a notable segment of surgical preference. Hip Resurfacing Implants showcase a unique approach by preserving more of the natural femoral bone, appealing to a specific patient base looking for less invasive options and quicker recovery, although they are more common in younger patients who are more active.

Additionally, Revision Hip Replacement Implants are paramount in addressing complications from previous surgeries, such as implant wear or failure, highlighting a robust opportunity for growth as the population ages and the number of primary hip replacement procedures rises. 

Collectively, these product types underscore the intense focus on patient-centric solutions in the US Hip Implants Market. Advances in material technology and surgical techniques are continuously driving innovation in each of these categories, positioning the market for sustained growth. Furthermore, healthcare policies and reimbursement practices from government sources play a pivotal role in shaping market access and deployment strategies for these implants, making it crucial for stakeholders to stay informed on regulatory frameworks that impact usage and availability of these vital orthopedic solutions.

Thus, the diverse range of product types available not only addresses the varying needs of patients but also reflects the ongoing evolution of the US Hip Implants Market, driven by innovations and demographic shifts.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Hip Implants Market End User Insights**

The End User segment of the US Hip Implants Market highlights critical avenues for healthcare providers, including hospitals, orthopedic clinics, and ambulatory surgical centers. Hospitals generally serve as key facilitators for hip implant surgeries, given their capacity to offer comprehensive care and advanced technology, thus dominating the market landscape. Orthopedic clinics play a significant role by specializing in hip-related issues, providing tailored treatment and rehabilitation, which enhances the patient experience and outcomes. Ambulatory surgical centers, on the other hand, have been gaining traction due to their efficiency, lower costs, and convenience for patients seeking outpatient procedures.

This segment aligns well with the increasing demand for minimally invasive surgeries and efficient care delivery models. The need for timely interventions and high-quality care drives the growth of these end users, as patients often seek to minimize recovery time and maximize mobility. Overall, as the population ages and the prevalence of hip diseases rises, the End User segment is set to play a pivotal role in shaping the US Hip Implants Market landscape.

### **Hip Implants Market Material Insights**

The US Hip Implants Market, particularly the Material segment, showcases a diverse range of options reflecting advancements in medical technology and patient demands. Among the various materials, Metal-on-Polyethylene remains prevalent due to its reliability and affordability, appealing to a wide demographic. Conversely, Ceramic-on-Metal has gained traction for its reduced risk of wear and longevity, making it an attractive choice for younger patients seeking durability.

Metal-on-Metal implants held significant market presence earlier for their low wear rates but have faced scrutiny due to concerns regarding metal ion release.On the other hand, Ceramic-on-Polyethylene combines the benefits of traditional polyethylene with enhanced wear characteristics from ceramics, promoting a good balance between cost and performance. 

Lastly, the Ceramic-on-Ceramic option is noted for its minimal wear and excellent longevity, sought after in cases where maximum durability is essential. The demand for these materials continues to evolve, influenced by factors such as patient age, activity levels, and advancements in surgical techniques, resulting in a variety of offerings in the US Hip Implants Market.Market growth in this segment is driven by ongoing Research and Development initiatives focusing on improving implant performance and safety while addressing challenges related to patient outcomes and material compatibility.

## **US Hip Implants Market Key Players and Competitive Insights**

The US Hip Implants Market is characterized by a dynamic competitive landscape influenced by technological advancements, demographic shifts, and increasing awareness regarding joint health. This market comprises a diverse range of products aimed at addressing various hip conditions, including osteoarthritis and fractures. The competitive insights into this market reveal a focus on innovation, quality, and patient outcomes as manufacturers strive to enhance their market positions. Companies engage in strategic partnerships, mergers and acquisitions, and extensive research and development to deliver products that meet the evolving demands of healthcare providers and patients alike.

The regulatory environment and clinical evidence supporting the efficacy and safety of hip implants also play a critical role in shaping competition among industry players.

Smith and Nephew operates as a significant player in the US Hip Implants Market, showcasing a robust portfolio of innovative products designed for hip procedures. Their emphasis on cutting-edge technology, such as their advancements in minimally invasive surgical techniques, enhances their reputation among healthcare professionals and patients. Smith and Nephew maintains a broad market presence characterized by strong relationships with orthopedic surgeons and hospitals, which further consolidates their position in the market. The company's commitment to quality and continuous improvement is evident in their wide range of hip implants, which cater to various patient needs, ultimately bolstering their competitive edge.

Their dedication to educational initiatives for healthcare providers and ongoing investment in research initiatives demonstrates their strength in delivering optimal solutions in the hip implant sector.

MicroPort Orthopedics holds a notable presence in the US Hip Implants Market, focusing on providing comprehensive solutions that enhance patient mobility and improve surgical outcomes. The company's product line includes innovative hip implant systems designed to accommodate a diverse range of patient anatomies and preferences. MicroPort's strengths lie in its ability to synergize with healthcare providers, continuously enhancing their offerings through collaborative partnerships and technology advancements. They have, in recent years, pursued strategic mergers and acquisitions to solidify their foothold, expand their product innovations, and streamline distribution channels across the US.

These moves have allowed MicroPort Orthopedics to further establish the quality and reliability of their hip implants, ultimately positioning themselves favorably in the competitive landscape of the US market.

### **Key Companies in the US Hip Implants Market Include**

### **US Hip Implants Market Industry Developments**

The US Hip Implants Market has observed significant developments recently, notably the ongoing advancements in implant technology and materials. Companies such as Smith and Nephew, MicroPort Orthopedics, and Stryker are increasingly focusing on minimally invasive procedures, enhancing recovery times and patient outcomes. Notably, in July 2023, Zimmer Biomet made headlines with its launch of a new hip implant designed to improve stabilization and longevity, which is expected to capture a notable market share. The market is also seeing active mergers and acquisitions with Medtronic acquiring Mazor Robotics in June 2021, emphasizing robotic surgery's growing role.

Growth in the market valuation is evident as demand for hip implants rises due to the aging population and increasing prevalence of obesity. This explains the projected market expansion, with a compound annual growth rate expected to reach 5-6% over the next few years. Furthermore, regulatory frameworks and reimbursement policies from Medicare and Medicaid are evolving, influencing market dynamics significantly. Overall, the United States hip implants sector is experiencing robust growth driven by technological innovation, mergers and acquisitions, and demographic changes.

## **US Hip Implants Market Segmentation Insights**

### **Hip Implants Market Product Type Outlook**

### **Hip Implants Market End User Outlook**

### **Hip Implants Market Material Outlook**

## Market Drivers

### Increased Healthcare Expenditure

Rising healthcare expenditure in the US is a significant driver for the hip implants market. With healthcare spending projected to reach approximately $6 trillion by 2027, there is a growing investment in surgical procedures, including hip replacements. This increase in funding allows for better access to advanced medical technologies and improved surgical techniques, which in turn boosts the demand for hip implants. The hip implants market benefits from this trend as hospitals and clinics are more likely to invest in high-quality implant devices to enhance patient care. Consequently, the market is expected to grow as healthcare providers respond to the increasing demand for effective hip replacement solutions.

### Innovations in Implant Materials

Advancements in materials science have led to the development of more durable and biocompatible materials for hip implants. Innovations such as ceramic-on-ceramic and highly cross-linked polyethylene have shown promising results in reducing wear and improving longevity. These advancements are crucial for the hip implants market, as they address concerns regarding implant failure and the need for revision surgeries. The introduction of new materials not only enhances patient outcomes but also drives market growth by attracting healthcare providers to adopt the latest technologies. The hip implants market is poised for expansion as these innovative materials gain acceptance among surgeons and patients alike.

### Growing Awareness of Joint Health

There is a notable increase in public awareness regarding joint health and the importance of early intervention for hip disorders. Educational campaigns and initiatives by healthcare organizations are informing the population about the benefits of timely surgical options, including hip implants. This heightened awareness is likely to lead to more individuals seeking medical advice and treatment for hip-related issues. As a result, the hip implants market is expected to see a rise in demand as patients become more proactive in managing their joint health. This trend may also encourage healthcare providers to offer more comprehensive treatment plans that include hip implant options.

### Rising Prevalence of Hip Disorders

The increasing incidence of hip disorders, including osteoarthritis and hip fractures, is a primary driver for the hip implants market. As the population ages, the prevalence of these conditions rises, leading to a greater demand for surgical interventions. In the US, it is estimated that over 27 million individuals suffer from osteoarthritis, with a significant portion requiring hip replacement surgeries. This trend indicates a growing market for hip implants, as healthcare providers seek effective solutions to manage pain and restore mobility. The hip implants market is likely to experience substantial growth as more patients seek surgical options to alleviate their conditions, thereby increasing the overall demand for hip implant devices.

### Expansion of Minimally Invasive Surgical Techniques

The expansion of minimally invasive surgical techniques is transforming the landscape of the hip implants market. These techniques, which involve smaller incisions and reduced recovery times, are becoming increasingly popular among both surgeons and patients. As more healthcare facilities adopt these methods, the demand for hip implants is likely to rise, as patients prefer options that minimize pain and expedite recovery. The hip implants market stands to benefit from this trend, as advancements in surgical techniques lead to improved patient outcomes and satisfaction. This shift towards minimally invasive procedures may also encourage more individuals to consider hip replacement surgery, further driving market growth.

## Future Outlook

The [Hip Implants Market](https://www.marketresearchfuture.com/reports/hip-implants-market-8448) is projected to grow at a 3.37% CAGR from 2025 to 2035, driven by technological advancements, increasing aging population, and rising healthcare expenditure.

**New opportunities:**

- Development of personalized implant solutions using 3D printing technology. Expansion of telehealth services for post-operative care management. Strategic partnerships with rehabilitation centers for integrated patient care.

By 2035, the hip implants market is expected to achieve substantial growth, reflecting evolving healthcare needs.

## Segment Insights

### By Product: Total Hip Implants (Largest) vs. Revision Hip Implants (Fastest-Growing)

In the US hip implants market, Total Hip Implants hold a significant share, driven by their widespread adoption among patients with severe hip joint conditions. They are the preferred choice for primary surgeries, comprising the majority of market sales. In contrast, Revision Hip Implants have seen increasing demand due to the rising number of joint replacements and subsequent complications that necessitate revision surgeries. This segment, focused on repairing or replacing failed implants, is rapidly gaining traction in the market.

The growth trends in this segment are primarily influenced by an aging population and the increasing prevalence of conditions such as arthritis and obesity, leading to more hip replacement procedures. Furthermore, advancements in implant technology and materials have enhanced the lifespan and performance of these devices, contributing to the growing adoption of Revision Hip Implants. The market is also supported by the rising awareness of the benefits of hip surgeries and improved surgical techniques, which encourage more patients to seek these treatments.

Total Hip Implants (Dominant) vs. Revision Hip Implants (Emerging)

Total Hip Implants are recognized for their reliability and effectiveness in treating end-stage hip diseases, representing a stable segment of the market. They offer significant functional improvements for patients, helping them regain mobility. With modern designs and materials, they have shown durability and reduced complications. Conversely, Revision Hip Implants are emerging as a critical segment due to the growing need for repeat surgeries in patients with existing implants. As technologies advance, these revision systems are being designed to address specific complications encountered in primary hip implants. Their growth is indicative of a trend toward personalized patient care and tailored solutions in orthopedics, appealing to surgeons looking for reliable options in complex cases.

### By End-User: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

The US hip implants market is significantly influenced by the end-user segment, where hospitals hold the largest market share. Orthopedic clinics also contribute substantially, but their share is smaller compared to hospitals. Ambulatory surgical centers are rapidly gaining ground, reflecting a noteworthy shift in patient care modalities. Overall, hospitals remain dominant, yet the growth of outpatient services is reshaping market dynamics.

In recent years, the trend towards outpatient procedures has accelerated, particularly favoring ambulatory surgical centers. This shift is driven by advancements in surgical techniques and technologies that facilitate quicker recoveries and lower patient costs. Additionally, increasing demand for hip implant surgeries due to a rising geriatric population is propelling growth in orthopedic clinics. As the landscape continues to evolve, the competition among these end-users is set to intensify, presenting opportunities for innovation and better patient experiences.

Hospitals (Dominant) vs. Ambulatory Surgical Centers (Emerging)

Hospitals play a central role in the US hip implants market, characterized by their infrastructure, comprehensive care facilities, and experienced surgical teams. They offer a full range of orthopedic services, which contributes to their dominant position in hip implant procedures. Conversely, ambulatory surgical centers are emerging as a viable alternative for certain hip surgeries, particularly for outpatient procedures. These facilities are increasingly favored for their efficiency, cost-effectiveness, and shorter recovery times. This duality within the market highlights a shift towards more versatile care options, appealing to both patient preferences and healthcare providers aiming to optimize resource utilization.

### By Material: Metal-on-Polyethylene (Largest) vs. Ceramic-on-Metal (Fastest-Growing)

In the US hip implants market, the material segment is led by Metal-on-Polyethylene, which captures a significant market share, reflecting its long-standing preference among healthcare providers due to its durability and proven performance. Conversely, Ceramic-on-Metal is emerging rapidly, appealing to patients and surgeons searching for advanced solutions that offer longevity and reduced wear particles compared to traditional options.

The growth trends within this segment are driven by increasing patient awareness about implant longevity and the rising demand for minimally invasive procedures. Innovations in ceramic technology are enabling the Ceramic-on-Metal segment to gain traction, making it a preferred choice among younger patients who prioritize durability. The evolving landscape indicates both segments will continue to shape the market dynamics significantly in the coming years.

Metal-on-Polyethylene (Dominant) vs. Ceramic-on-Metal (Emerging)

Metal-on-Polyethylene implants have established themselves as the dominant option in the US hip implants market due to their cost-effectiveness and reliability. These implants consist of a metal ball that articulates against a polyethylene socket, providing an optimal balance of performance and longevity. On the other hand, Ceramic-on-Metal implants are gaining momentum as an emerging choice, particularly among younger, active patients. They offer better wear resistance and lower risk of osteolysis, positioning themselves as a promising alternative as technological advancements continue to improve their design and functionality. The juxtaposition of these materials signifies a transition towards more optimized solutions in hip surgeries, reflecting evolving patient needs.

## Competitive Benchmarking

The hip implants market is characterized by a competitive landscape that is both dynamic and multifaceted. Key growth drivers include an aging population, increasing prevalence of hip-related disorders, and advancements in implant technology. Major players such as Johnson & Johnson (US), Stryker Corporation (US), and Zimmer Biomet (US) are strategically positioned to leverage these trends. Johnson & Johnson (US) focuses on innovation through its DePuy Synthes division, emphasizing the development of next-generation implants. Stryker Corporation (US) has adopted a strategy centered on digital transformation, integrating advanced technologies into its product offerings. Zimmer Biomet (US) is pursuing regional expansion, particularly in emerging markets, to enhance its market share. Collectively, these strategies contribute to a competitive environment that is increasingly defined by technological advancements and market responsiveness.Key business tactics within the hip implants market include localizing manufacturing and optimizing supply chains to enhance efficiency and reduce costs. The market structure appears moderately fragmented, with several key players holding substantial market shares. This fragmentation allows for a diverse range of products and innovations, while the collective influence of these major companies shapes market dynamics and competitive strategies.
In October Stryker Corporation (US) announced the launch of its new robotic-assisted surgical system, which is designed to enhance precision in hip implant procedures. This strategic move underscores Stryker's commitment to integrating cutting-edge technology into its offerings, potentially improving surgical outcomes and patient satisfaction. The introduction of this system may also position Stryker as a leader in the growing trend of robotic-assisted surgeries, thereby enhancing its competitive edge.
In September Zimmer Biomet (US) expanded its partnership with a leading telehealth provider to enhance remote patient monitoring capabilities for hip implant recipients. This collaboration aims to improve patient engagement and post-operative care, reflecting a broader trend towards digital health solutions in the medical device sector. By investing in telehealth, Zimmer Biomet (US) not only addresses patient needs but also strengthens its market position in an increasingly digital healthcare landscape.
In August Johnson & Johnson (US) unveiled a new line of biodegradable hip implants, which are designed to reduce environmental impact while maintaining performance standards. This initiative aligns with the growing emphasis on sustainability within the medical device industry. By prioritizing eco-friendly solutions, Johnson & Johnson (US) may attract environmentally conscious consumers and healthcare providers, thereby differentiating itself in a competitive market.
As of November current competitive trends in the hip implants market include a pronounced focus on digitalization, sustainability, and the integration of artificial intelligence (AI) into product development. Strategic alliances are increasingly shaping the landscape, enabling companies to pool resources and expertise to drive innovation. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition towards a focus on technological innovation, supply chain reliability, and sustainable practices. This shift may redefine market dynamics, compelling companies to adapt and innovate continuously to maintain their competitive positions.

## Recent News & Developments

The US Hip Implants Market has observed significant developments recently, notably the ongoing advancements in implant technology and materials. Companies such as Smith and Nephew, MicroPort Orthopedics, and Stryker are increasingly focusing on minimally invasive procedures, enhancing recovery times and patient outcomes. Notably, in July 2023, Zimmer Biomet made headlines with its launch of a new hip implant designed to improve stabilization and longevity, which is expected to capture a notable market share. The market is also seeing active mergers and acquisitions with Medtronic acquiring Mazor Robotics in June 2021, emphasizing robotic surgery's growing role.

Growth in the market valuation is evident as demand for hip implants rises due to the aging population and increasing prevalence of obesity. This explains the projected market expansion, with a compound annual growth rate expected to reach 5-6% over the next few years. Furthermore, regulatory frameworks and reimbursement policies from Medicare and Medicaid are evolving, influencing market dynamics significantly. Overall, the United States hip implants sector is experiencing robust growth driven by technological innovation, mergers and acquisitions, and demographic changes.

## Report Scope

| MARKET SIZE 2024 | 2500.0(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 2584.25(USD Million) |
| MARKET SIZE 2035 | 3600.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 3.37% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Johnson & Johnson (US), Stryker Corporation (US), Zimmer Biomet (US), Smith & Nephew (GB), DePuy Synthes (US), Medtronic (US), B. Braun Melsungen AG (DE), Exactech (US) |
| Segments Covered | Product, End-User, Material |
| Key Market Opportunities | Integration of advanced materials and minimally invasive techniques enhances growth potential in the hip implants market. |
| Key Market Dynamics | Technological advancements and regulatory changes drive innovation and competition in the hip implants market. |
| Countries Covered | US |

## Frequently Asked Questions

**Q: What is the current valuation of the US hip implants market as of 2024?**
A: The US hip implants market was valued at $2500.0 Million in 2024.

**Q: What is the projected market valuation for the US hip implants market in 2035?**
A: The projected valuation for the US hip implants market in 2035 is $3600.0 Million.

**Q: What is the expected CAGR for the US hip implants market during the forecast period 2025 - 2035?**
A: The expected CAGR for the US hip implants market during the forecast period 2025 - 2035 is 3.37%.

**Q: Which companies are considered key players in the US hip implants market?**
A: Key players in the US hip implants market include Johnson & Johnson, Stryker Corporation, Zimmer Biomet, Smith & Nephew, DePuy Synthes, Medtronic, B. Braun Melsungen AG, and Exactech.

**Q: What are the main product segments in the US hip implants market?**
A: The main product segments in the US hip implants market include Total Hip implants, Fixed-Bearing Hip Implants, Mobile-Bearing Total Hip Implants, Partial Hip implants, Hip Resurfacing Implants, and Revision Hip implants.

**Q: What was the market size for Total Hip implants in 2024?**
A: The market size for Total Hip implants was between $1000.0 Million and $1500.0 Million in 2024.

**Q: How do the valuations of different end-user segments compare in the US hip implants market?**
A: In 2024, hospitals had a market size of $1000.0 Million to $1500.0 Million, orthopedic clinics ranged from $800.0 Million to $1200.0 Million, and ambulatory surgical centers were valued between $700.0 Million and $900.0 Million.

**Q: What materials are predominantly used in hip implants within the US market?**
A: The predominant materials used in hip implants include Metal-on-Polyethylene, Ceramic-on-Metal, Metal-on-Metal, Ceramic-on-Polyethylene, and Ceramic-on-Ceramic.

**Q: What was the valuation range for Fixed-Bearing Hip Implants in 2024?**
A: The valuation range for Fixed-Bearing Hip Implants was between $600.0 Million and $900.0 Million in 2024.

**Q: What is the anticipated growth trend for the US hip implants market in the coming years?**
A: The US hip implants market is anticipated to grow steadily, reaching a valuation of $3600.0 Million by 2035, reflecting a positive growth trend.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-hip-implants-market-19388*